throbber
Cysteine: a conditionally essential amino acid in low-birth-weight
`preterm infants? 1- 4
`
`Maaike A Riedijk, Ron HT van Beek, Gardi Voortman, Henrica MA de Bie, Anne CM Dassel, and
`Johannes B van Goudoever
`
`ABSTRACT
`Background: Cyst( e )ine can be synthesized de novo from methio(cid:173)
`nine and serine and is, therefore, a nonessential amino acid in human
`adults. Several studies have suggested that cyst(e)ine might be a
`conditionally essential amino acid in preterm infants because of
`biochemical immaturity. No data are available on cyst( e )ine require(cid:173)
`ments in low-birth-weight (LBW) preterm infants.
`Objective: The aim was to determine cyst( e )ine requirements in LBW
`infants with gestational ages from 32 to 34 wk, measured 1 mo after birth
`with the use of the indicator amino acid oxidation technique.
`Design: LBW infants were randomly assigned to 1 or 2 of the 5
`formulas containing graded cystine concentrations (11, 22, 32, 43, or
`65 mg cyst(e)ine/100 mL) and generous amounts of methionine.
`After 24-h adaptation, cyst( e )ine requirement was determined by
`13CO2 release from [l- 13C]phenylalanine in expired breath. 13CO2
`enrichment was measured by isotopic ratio mass spectrometry.
`Results: Cyst( e )ine requirement was determined in 25 LBW infants
`withamean(±SD)gestationalageof33 ± 1 wkandbirthweightof
`1.78 ± 0.32 kg. Fractional oxidation of [1 - 13C]phenylalanine did not
`differ between the 5 groups.
`Conclusions: There is no evidence for limited endogenous
`cyst(e)ine synthesis in 4-wk-old LBW preterm infants born at ges(cid:173)
`tational ages from 32 to 34 wk. It is safe to conclude that the
`cyst( e )ine requirement is < 18 mg · kg- 1 • d- 1 providing generous
`amounts of methionine and that cyst( e )ine is probably not a condi(cid:173)
`tionally essential amino acid in fully enterally fed LBW preterm
`Am J Clin Nutr 2007;86:1120-5.
`infants born at 32-34 wk.
`
`KEY WORDS
`oxidation, nutrition
`
`Amino acid requirements, indicator amino acid
`
`INTRODUCTION
`Cyst(e)ine is a sulfur-containing amino acid that is not essen(cid:173)
`tial in humans. The human body synthesizes cyst( e )ine de novo
`from methionine, the only essential sulfur-containing amino
`acid, and serine. Cyst( e )ine has several important metabolic
`functions. First, like all other amino acids it is involved in growth
`and protein synthesis. Furthermore, it is a precursor for the tri(cid:173)
`peptide glutathione, an important intracellular antioxidant. Then,
`it is also a precursor for the production of taurine, another anti(cid:173)
`oxidant, and sulfate.
`Some nonessential amino acids are classified as conditionally
`essential. These amino acids may become temporarily essential
`when synthesis during rapid growth or critical illness is insufficient.
`
`Cyst( e )ine is believed to be conditionally essential in preterm infants
`because of biochemical immaturity of the enzyme cystathionase
`(EC 4.4.1.1) that is involved in cyst(e)ine synthesis (1-3). It is,
`therefore, important to know the exact cyst( e )ine requirement of
`preterm infants and also in view of the higher amino acid re(cid:173)
`quirement as a result of rapid growth and development.
`Different methods are used to estimate individual amino acid
`requirements, eg, the nitrogen balance method, growth rate,
`plasma amino acid patterns, and the factorial approach. The first
`reports on amino acid requirements in neonates were based on
`nitrogen balance and weight gain rate ( 4, 5). Nitrogen balance has
`several limitations (6), for instance, it requires 7-10 d to adaptto
`the test diet (7). Because present-day practice will not allow
`neonates to be maintained on either deficient or excess intakes of
`amino acids for a minimum of 7 d, no recent requirement studies
`have used this method in preterm infants.
`At present, the factorial approach is used to define amino acid
`requirements in infants (8). This model is based on fetal protein
`accretion during normal intrauterine development. Accretion
`data are derived from body carcass analysis of stillborn preterm
`infants, some born > 100 y ago (9, 10). Not all data are suitable
`as reference material; gestational age and cause of death were not
`accurately obtained (11), and, in view of this study, cysteine
`content of the body was not determined. The current recommen(cid:173)
`dation for cyst(e)ine requirement for preterm infants, ie, 66-95
`mg · kg- 1 • d- 1, is based on the minimum and maximum
`amounts of each amino acid present in the amounts of human
`
`1 From the Department of Pediatrics, Division ofNeonatology (MAR and
`JBvG), Mass Spectrometry Laboratory (GV), Erasmus MC-Sophia Chil(cid:173)
`dren' s Hospital, University Medical Center, Rotterdam, the Netherlands; the
`Department of Pediatrics, Amphia Hospital, Breda, the Netherlands
`(RHTvB); the Department of Pediatrics, Vlietland Hospital, Vlaardingen, the
`Netherlands (HMAdB); and the Department of Pediatrics, Deventer Hospi(cid:173)
`tal, Deventer, the Netherlands (ACMD).
`2 "Cyst( e )ine" is used throughout to designate any undefined combination
`of cysteine and cystine. The terms "cysteine" and "cystine" are used to
`designate the specific amino acids.
`3 Supported by the Sophia Foundation for Medical Research (grant 417),
`the Netherlands, and the Nutricia Research Foundation, Wageningen, the
`Netherlands.
`4 Reprints not available. Address correspondence to JB van Goudoever,
`Erasmus MC-Sophia Children's Hospital, Department of Pediatrics, Divi(cid:173)
`sion ofNeonatology, Dr Molewaterplein 60, 3015 GJ Rotterdam, the Neth(cid:173)
`erlands. E-mail: j.vangoudoever@erasmusmc.nl.
`Received January 22, 2007.
`Accepted for publication June 6, 2007.
`
`1120
`
`Am J Clin Nutr 2007;86: 1120-5. Printed in USA. © 2007 American Society for Nutrition
`
`Eton Ex. 1049
`1 of 6
`
`

`

`CYST(E)INE REQUIREMENTS IN LBW INFANTS
`
`1121
`
`TABLE 1
`Amino acid profiles of the study formulas
`
`Amino acid
`
`Formula 1
`
`Formula2
`
`Formula3
`
`Formula4
`
`Formula5
`
`L-Alanine (mg/170 mL)
`L-Arginine (mg/170 mL)
`L-Aspartic acid (mg/170 mL)
`L-Cystine (mg/170 mL)
`L-Glycine (mg/170 mL)
`L-Histidine (mg/170 mL)
`L-lsoleucine (mg/170 mL)
`L-Leucine (mg/170 mL)
`L-Lysine (mg/170 mL)
`L-Methionine (mg/170 mL)
`L-Proline (mg/170 mL)
`L-Phenylalanine (mg/170 mL)
`L-Serine (mg/170 mL)
`L-Threonine (mg/170 mL)
`L-Tryptophan (mg/170 mL)
`L-Tyrosine (mg/170 mL)
`L-Valine (mg/170 mL)
`L-Asparagine (mg/170 mL)
`L-Citrulline (mg/170 mL)
`L-Carnitine (mg/170 mL)
`L-Taurine (mg/170 mL)
`L-Glutarnine/glutamate (mg/170 mL)
`Total (g/170 mL)
`
`166
`292
`274
`18
`259
`168
`266
`435
`300
`70
`313
`197
`194
`215
`88
`197
`282
`0
`0
`3
`8
`371
`4.12
`
`166
`292
`274
`36
`259
`168
`266
`435
`300
`70
`313
`197
`194
`215
`88
`197
`282
`0
`0
`3
`8
`371
`4.13
`
`166
`292
`274
`54
`259
`168
`266
`435
`300
`70
`313
`197
`194
`215
`88
`197
`282
`0
`0
`3
`8
`371
`4.14
`
`166
`292
`274
`72
`259
`168
`266
`435
`300
`70
`313
`197
`194
`215
`88
`197
`282
`0
`0
`3
`8
`371
`4.17
`
`166
`292
`274
`109
`259
`168
`266
`435
`300
`70
`313
`197
`194
`215
`88
`197
`282
`0
`0
`3
`8
`371
`4.21
`
`milk protein corresponding to the recommended minimum and
`maximum protein contents of 3.0 g/120 kcal and 4.3 g/120 kcal,
`respectively (8).
`Because methionine is the precursor of cyst(e)ine, the methi(cid:173)
`onine intake needs to be taken into account as well. The current
`estimated methionine requirement for preterm infants is 48-69
`mg· kg- 1 • d- 1 (8). To ensure an adequate methionine intake, the
`study formula supplied an amount of70 mg methionine · kg- 1 • d- 1•
`Shoveller et al (12) determined the total sulfur amino acid require(cid:173)
`ment in enterally fed neonatal piglets when no dietary cysteine was
`provided. The extrapolation from this piglet study results in a me(cid:173)
`thionine intake of 84 mg • kg - i • d- 1 for the human neonate, which
`is slightly above the current recommendations (8).
`The objective of the present study was to use indicator amino
`acid oxidation (IAAO) with [1- 13C]phenylalanine to estimate
`cyst(e)ine requirements in fully enterally fed low-birth-weight
`(LBW) infants supplied with an adequate methionine intake. We
`hypothesized that cyst(e)ine is a conditionally essential amino
`acid for these infants.
`
`SUBJECTS AND METHODS
`
`Subjects
`Subjects eligible for the study were LBW infants with gesta(cid:173)
`tional age (GA) between 32 and 34 wk, admitted to the neonatal
`department of the Amphia Hospital, Breda; Vlietland Hospital,
`Vlaardingen; or Deventer Hospital, Deventer (all: the Nether(cid:173)
`lands). The infants needed to be clinically stable during the study,
`and those with any congenital or gastrointestinal disease were
`excluded. All tolerated full enteral feeding and were partly fed
`through a nasogastric feeding tube and partly bottle-fed. The
`study protocol was approved by The Central Committee on Re(cid:173)
`search Involving Human Subjects (CCMO) and the Erasmus MC
`
`Institutional Review Board. Written and informed consent was
`obtained from both parents of each subject.
`
`Study formula
`We used 5 study formulas that contained graded cyst( e )ine
`concentrations: 11, 22, 32, 43, and 65 mg cystine/100 mL (Xcys/
`Neocate; Nutricia Nederland BV, Zoetermeer, the Netherlands/
`SHS International, Liverpool, United Kingdom). Infants were
`enrolled in the study when they tolerated full enteral feeding
`(> 150mL · kg- 1 • d- 1). Exceptforthecyst(e)ineconcentration,
`the 5 formulas did not differ in amino acid composition
`(Table 1), and consequently the nitrogen content increased
`slightly from 0.37 mg nitrogen/100 mL (formula 1) to 0.38 mg
`nitrogen/100 mL (formula 5). The graded cyst(e)ine concentra(cid:173)
`tions of the study formulas were based on the current estimated
`cyst(e)ine requirement for preterm infants (8), which is 66-95
`mg · kg- 1 • d- 1, and is based on the minimum and maximum
`amounts of each amino acid present in the amounts of human
`milk protein corresponding to the recommended minimum and
`maximum protein contents of 3.0 g/120 kcal and 4.3 g/120 kcal,
`respectively. We decided to test 3 cyst(e)ine intakes above and 2
`cyst( e )ine intakes below the estimated cyst( e )ine requirements
`for formula-fed preterm infants. Methionine content was similar
`in all formulas and was supplied generously.
`
`Study design and tracer protocol
`Cyst( e )ine requirement was measured ""1 mo after birth
`(range: 35-37 wk postmenstrual age). Infants were randomly
`assigned to at least one of the study formulas. The study diet was
`initiated 24 h before start of the oxidation study, and the dietary
`intake was not changed until the tracer protocol was finished. All
`subjects received ""170 mL formula· kg- 1 • d- 1 to ensure that
`all essential amino acids other than cyst( e )ine were in excess
`
`Eton Ex. 1049
`2 of 6
`
`

`

`1122
`
`RIEDUK ET AL
`
`(Table 1) and, therefore, were not limiting for protein synthesis.
`Before the introduction of the study formula, almost all infants
`received their mothers' (expressed) breast milk, and only a few
`infants received standard preterm formula (Nenatal; Nutricia,
`Zoetermeer, the Netherlands). The cyst(e)ine concentration of
`human milk varies widely, but the preterm formula provided 35
`cyst(e)ine/100 mL.
`The IAAO technique uses as indicator a labeled essential
`amino acid that is different than the test amino acid. The indicator
`is independent of the different intake amounts of the test amino
`acid. If the test amino acid is deficient in the diet, this will limit
`overall protein synthesis and all other essential amino acids will
`be oxidized. Increasing the dietary intake of the test amino acid
`will linearly decrease oxidation of the indicator until requirement
`of the test amino acid is met. We chose [l- 13C]phenylalanine as
`the indicator (13).
`After 24-h adaptation, subjects received a primed (10 µ,moll
`kg) continuous (10 µ,mo!· kg- 1 • h- 1) enteral infusion of
`[ 13C]bicarbonate [sterile pyrogen free, 99 atom percent excess
`(APE); Cambridge Isotopes, Woburn, MA] for 2.5 h to quantify
`individual carbon dioxide production. We infused the tracer en(cid:173)
`terally to minimize invasiveness, which was validated by our
`group (14). The labeled sodium bicarbonate infusion was di(cid:173)
`rectly followed by a primed (30 µ,mol/kg) continuous (30
`µ,mo!· kg- 1 • h- 1) enteral infusion of [1- 13C]phenylalanine (93
`APE; Cambridge Isotopes) for 5 h. One hour before the start of
`the oxidation study, the feeding regimen was changed into con(cid:173)
`tinuous drip-feeding. Enterally infused tracer was mixed with the
`study formula and infused continuously by an infusion pump
`through the nasogastric tube. All infants were breathing sponta(cid:173)
`neously, and 14 infants needed supplemental oxygen by a nasal
`prong.
`Breath samples were obtained with the use of the direct sam(cid:173)
`pling method described by van der Schoor et al (15). In brief, a
`6-French gastric tube (6 Ch Argyle; Cherwood Medical, Tul(cid:173)
`lamore, Ireland) was inserted 1-1.5 cm into the nasopharynx, and
`end-tidal breath was taken slowly with a syringe connected at the
`end. Collected air was transferred into 10-mL sterile, non(cid:173)
`silicon-coated evacuated glass tubes (Van Loenen Instruments,
`Zaandam, the Netherlands) and stored at room temperature until
`analysis. Baseline samples were obtained 15 and 5 min before
`starting tracer infusion. Duplicate 13C-enriched breath samples
`were collected every 30 min and every 15 min during the last 45
`min of the tracer infusion.
`
`Analytic methods and calculations
`13CO2 isotopic enrichment in expired air was measured by
`isotope ratio mass spectrometry (ABCA; Europe Scientific, Van
`Loenen Instruments, Leiden, the Netherlands) and expressed as
`APE above baseline (15). APE was plotted relative to time.
`It is necessary to determine the individual carbon dioxide
`production to determine the rate of substrate oxidation. In gen(cid:173)
`eral, the rate of oxidation is calculated by multiplying the isotopic
`enrichment of carbon dioxide in breath by the total rate of carbon
`dioxide excreted; the latter needs to be determined by indirect
`calorimetry to estimate the rate of carbon dioxide production.
`Alternatively, body carbon dioxide production can be deter(cid:173)
`mined by quantifying the excretion of 13CO2 in expired air during
`[ 13C]sodium bicarbonate infusion, which avoids the quantifica(cid:173)
`tion of total expired air (15).
`
`(in
`production
`dioxide
`carbon
`body
`Estimated
`mmol · kg- 1 • h- 1) was calculated as described previously (14).
`The rate of fractional [l- 13C]phenylalanine oxidation was cal(cid:173)
`culated as follows:
`
`Fractional pheny !alanine oxidation ( % )
`
`= [IErHE X iB]/[iPHE X IEB] X 100
`
`(1)
`
`where IErHE is the 13C isotopic enrichment in expired air during
`[1-13C]phenylalanine infusion (in APE), is is the infusion rate of
`[ 13C]bicarbonate (in µ,mo!· kg- 1 • h- 1), irHE is the infusion rate
`of [l- 13C]phenylalanine (in µ,mo! · kg- 1 • h- 1), and IE8 is the
`13C isotopic enrichment in expired air during [13C]bicarbonate
`infusion (16).
`
`Statistical analysis
`Descriptive data are expressed as mean ± SD. Steady state of
`13CO2 in expired breath during the [ l -13C]phenylalanine was
`achieved when the linear factor of the slope was found not to be
`significantly different from zero (P 2:: 0.05). The cyst(e)ine re(cid:173)
`quirement was determined with the IAAO method. The indicator
`oxidation rate is plotted against the varying dietary intakes of
`cyst( e )ine. The inflection or breakpoint in the indicator oxidation
`rate represents the physiologic requirement of cyst( e )ine (17).
`Data were analyzed with the use of mixed model analysis of
`variance in SPSS SOFTWARE (version 14.0; SPSS Inc, Chi(cid:173)
`cago, IL), while encoding the patients who participated twice
`with the same number. Repeated measures analysis of variance
`was performed on primary and derived variables to assess the
`effects of dietary intake and of subjects. Regression analysis was
`performed to analyze oxidation rates. Power calculation showed
`that, assuming 5 formula groups with a group variance of 16, an
`intergroup variance of 5.5, and a power of 80%, a breakpoint
`should be detected with 6 subjects per group. Statistical signifi(cid:173)
`cance was assumed at the 5% level of significance (P :5 0.05).
`
`RESULTS
`We included 25 LBW infants (12 boys, 13 girls) born at mean
`(±SD) GA of33 ± 1 wk (range: 32-34 wk). They were studied
`at mean postmenstrual age of 36 ± 1 wk (range: 35-38 wk), ie,
`approximately at postnatal age 1 mo. Subject characteristics are
`depicted in Table 2. Five infants participated twice and received
`2 different study formulas. Aiming at 6 measurements per for(cid:173)
`mula, we performed a total of 30 labeled phenylalanine oxidation
`rate measurements in these 25 infants.
`GA, study age, birth weight, and study weight did not differ
`between the 5 formula groups as shown in Table 2. In addition,
`the total enteral intake did not differ between the 5 formulas (P =
`0.07). Although the nitrogen content of study formula 5 was
`somewhat higher, the nitrogen intake did not differ significantly
`between the formula groups (P = 0.25).
`To detect any differences between the 5 groups receiving the
`different formulas we corrected for sex, study age, and study
`weight. The baseline 13C enrichment in expired breath did not
`differ between the 5 formula groups ( -17 .24 ± 0.56, -16. 77 ±
`0.62, -17.95 ± 1.38, -17.87 ± 1.01, and -17.58 ± 1.55 Pee
`Dee Belemnite, respectively; P = 0.67) after correction for birth
`weight and study weight (Table 3). Each subject reached a pla(cid:173)
`teau during both [13C]bicarbonate and [l- 13C]phenylalanine
`tracer infusions. As an illustration, the 13C enrichments in
`
`Eton Ex. 1049
`3 of 6
`
`

`

`CYST(E)INE REQUIREMENTS IN LBW INFANTS
`
`1123
`
`TABLE 2
`Patient characteristics1
`
`Formula
`
`Subjects
`
`GA
`
`1
`2
`3
`4
`5
`All
`
`n
`
`6
`6
`6
`6
`6
`30
`
`wk
`33 ± I2
`32 ± 1
`33 ± 1
`33 ± 1
`32 ± 1
`33 ± 1
`
`SA
`
`wk
`
`36 ± 1
`35 ± 0
`36 ± 1
`36 ± 0
`36 ± 1
`36 ± 1
`
`BW
`
`SW
`
`kg
`1.88 ± 0.28
`1.81 ± 0.36
`1.81 ± 0.38
`1.81 ± 0.24
`1.58 ± 0.38
`1.78 ± 0.32
`
`kg
`2.26 ± 0.24
`2.10 ± 0.38
`2.17 ± 0.38
`2.17 ± 0.27
`2.04 ± 0.31
`2.15±0.31
`
`Enteral intake
`mL·kg- 1 •r 1
`170 ± 6
`167 ± 1
`167 ± 2
`163 ± 5
`166 ± 3
`167 ± 5
`
`Cyst(e)ine
`intake
`mg·kg- 1 •r 1
`18 ± 1
`36 ± 0
`54 ± 1
`70 ± 2
`108 ± 2
`
`SAA intake
`mg·kg- 1 -r 1
`89 ± 3
`105 ± 1
`123 ± 1
`138 ± 4
`177 ±4
`
`1 GA, gestational age; SA, study age; BW, birth weight; SW, study weight; SAA, sulfur amino acid. No significant differences were detected in GA
`(P = 0.20), SA (P = 0.38), BW (P = 0.55), SW (P = 0.86), or enteral intake (P = 0.07) between the 5 formula groups.
`2 i ± SD (all such values).
`
`expired breath during the infusion of [l- 13C]phenylalanine of
`6 subjects receiving 54 mg cyst(e)ine · kg- 1 • d- 1 are shown in
`Figure 1.
`The mean fractional [ 1-13C]pheny lalanine oxidation did not
`differ between the groups (P = 0.73). Regression of the data did
`not show a linear decrease in indicator oxidation rate, and con(cid:173)
`sequently a breakpoint is missing (Figure 2). A trend in the
`formula could not be detected (P = 0.90). This implies that the
`cyst( e )ine requirement under these circumstances is already met
`at an intake of 18 mg cystine · kg - I • d- 1• At the intakes of
`18-109 mg · kg- 1 • d- 1, cyst( e )ine is not the limiting amino acid
`for protein synthesis and is therefore not deficient in the diet.
`
`DISCUSSION
`To our knowledge this is the first study to determine the exact
`cyst( e )ine requirementin LBW infants. With the use of the IAAO
`method, we found it to be < 18 mg · kg- 1 • d- 1 1 mo after birth,
`which suggests that cyst(e)ine is not a conditionally essential
`amino acid in these infants at this age who are receiving generous
`amounts of methionine. The IAAO method is based on the as(cid:173)
`sumption that the partition of any essential amino acid between
`oxidation and protein synthesis is sensitive to the amount of the
`most limiting amino acid in the diet (17, 18). Thus, a limitation
`of this method is the necessity of providing all amino acids in
`excess, except for the one under study. Accordingly, insufficient
`
`amounts of essential amino acids could have resulted in another
`essential amino acid than cystine being limiting for protein syn(cid:173)
`thesis. However, we do not believe this is the case in this study,
`seeing that the fractional [1- 13C]phenylalanine oxidation did not
`differ between the 5 test diets and that essential amino acids were
`supplied in excess of the estimate dietary requirements for pre(cid:173)
`term infant formula ( 19). Although the dietary intake of formula
`1 (170 mL·kg- 1 ·d- 1) was higher than formula 4 (163
`mL · kg- 1 • d- 1),itdidnotsignificantlydiffer. Wedo not believe
`that this had a major influence on the obtained results. The higher
`intake of formula 1 could have resulted in a lower phenylalanine
`oxidation rate because of a slightly higher cyst( e )ine intake com(cid:173)
`pared with formula 2. However, we did not find a difference in
`the phenylalanine oxidation.
`The current guidelines on requirements of individual amino
`acids for infants are based on the factorial method. To calculate
`the deposit of each amino acid, growth rate is assumed to be
`constant at 15 g · kg- 1 • d- 1 for a fetus from 900 to 2400 g and
`protein retention at 70% of total protein intake. Furthermore, the
`protein maintenance requirement in preterm infants ranges from
`0.55 to0.75 g • kg- 1 • d- 1 (20). Fetal amino acid accretion during
`normal intrauterine growth was determined by Widdowson (21).
`Cyst( e )ine accretion by the human fetus was not determined,
`however; thus, the requirement could not be estimated by the
`factorial approach.
`
`TABLE 3
`Whole-body carbon dioxide production and fractional [13C]phenylalanine (phe) oxidation rates of 5 different cyst(e)ine intakes1
`
`Cyst( e )ine intake
`
`Baseline 13CO2
`
`PDB
`
`13CO2
`[ 13C]bicarb
`
`APE
`
`-17.24 ± 0.56
`
`0.0331 ± 0.0046
`
`Carbon dioxide
`production
`
`mmol • kg- 1 • d- 1
`30.78 ± 5.31
`
`13CO2
`[l-13C]phe
`
`APE
`
`0.0209 ± 0.0080
`
`Fractional oxidation
`of [ I- 13C]phe
`
`%
`20.32 ± 5.26
`
`18mg·kg- 1 ·d- 1
`(n = 6)
`36 mg· kg- 1 • d- 1
`(n = 6)
`54 mg· kg- 1 • d- 1
`(n = 6)
`72mg·kg- 1 ·d- 1
`(n = 6)
`109 mg· kg- 1 • d- 1
`(n = 6)
`1 All values are i ± SD. 13CO2, enrichment of 13C in expired air; PDB, Pee Dee Belemnite; bicarb, sodium bicarbonate; APE, atom percent excess. No
`significant differences were detected in baseline 13CO2 (P = 0.67), carbon dioxide production (P = 0.61), or fractional oxidation of labeled phenylalanine (P
`= 0.73) between the 5 formula groups.
`
`-16.77 ± 0.62
`
`0.0353 ± 0.0030
`
`28.19 ± 2.61
`
`0.0200 ± 0.0058
`
`18.73 ± 5.03
`
`-17.95 ± 1.38
`
`0.0339 ± 0.0035
`
`29.83 ± 3.08
`
`0.0206 ± 0.0043
`
`20.33 ± 4.15
`
`-17.87 ± 1.01
`
`0.0329 ± 0.0023
`
`30.20 ± 1.97
`
`0.0210 ± 0.0049
`
`21.48 ± 5.70
`
`-17.58 ± 1.55
`
`0.0344 ± 0.0028
`
`29.24 ± 2.22
`
`0.0197 ± 0.0054
`
`19.07 ± 4.93
`
`Eton Ex. 1049
`4 of 6
`
`

`

`1124
`
`0.04
`
`RIEDIJK ET AL
`
`iii' 0.03
`
`I I I I I I II
`~ I
`
`8 0.02
`..,
`-c
`Ill
`~ 0.01
`
`o.01o-1----.---------"'I""---,
`200
`250
`400
`450
`300
`350
`Time (min)
`FIGURE 1. Mean 13C enrichments in expired breath during enteral
`receiving 54 mg
`[l- 13C]-phenylalanine
`infusion
`in 6
`infants
`cyst(e)ine·kg- 1 ·d- 1 . Data are expressed as means± SDs. APE, atom
`percent excess.
`
`Little is known, too, about the biosynthetic capacity of non(cid:173)
`essential amino acids in preterm infants. In the early 1970s sev(cid:173)
`eral investigators reported that the transsulfuration pathway
`might be immature in preterm infants because of limited enzyme
`activity of cystathionase (1-3). Some found cystathionase activ(cid:173)
`ity to be absent in fetal liver tissues (2, 3). Zlotkin and Anderson
`(1) showed that cystathionine activity was limited but not iso(cid:173)
`lated to the liver and was also present in extrahepatic tissues
`(kidneys and adrenals). They also found in term and preterm
`infants that this activity increased after birth. Furthermore,
`Stegink and Den Besten (22) showed that plasma cysteine con(cid:173)
`centrations in adult humans fed a cystine-deficient diet intragas(cid:173)
`tricall y were significantly higher than in those fed the same diet
`intravenously. This finding suggests an important role in
`cyst( e )ine production for the gut and was confirmed in animal
`experiments. Neonatal piglets fed a cysteine-free diet enterally
`showed significantly higher plasma cysteine concentrations than
`did parenterally fed piglets (23). In addition, dietary methionine
`and plasma cysteine concentrations were positively correlated in
`enterally fed piglets but not in parenterally fed piglets.
`Earlier studies that investigated whether cyst(e)ine is an es(cid:173)
`sential amino acid in preterm infants were all performed during
`parenteral nutrition. Several of those studies reported low plasma
`
`. •
`-,----·-"···---:---------------------·-
`.
`.
`
`•
`
`I
`
`..-.
`,fl.
`C
`._..
`l!! 3
`_g
`a, ·-
`'C C
`·- a,
`>< -
`~ ';.2
`a, C
`§ 1!
`;,9; e .P 1
`IL-, =-
`
`O
`
`100
`75
`50
`25
`Cyst(e)ine intake (mg. kg-1 • d·')
`FIGURE 2. Fractional [l- 13C]phenylalanine oxidation plotted against
`increasing cyst(e)ine intake. Data are expressed as means± SDs. No differ(cid:173)
`ences could be detected between the fractional oxidation of [ l- 13C](cid:173)
`phenylalanine of the 5 different cyst(e)ine intakes (n = 6 per intake; P =
`0.73).
`
`125
`
`0
`
`a.
`
`~ ::, g
`(D a. a 3
`
`cysteine concentrations, with or without cysteine supplementa(cid:173)
`tion (24-26). Pohlandt (26) observed no differences in plasma
`cystine concentrations between preterm infants receiving only
`glucose intravenously and preterm infants fed a mixture of syn(cid:173)
`thetic amino acids free from cystine. In both groups cystine
`plasma concentrations were low, <5 µmol/L, indicating limited
`endogenous synthesis from methionine. Furthermore, Vina et al
`(25) and Miller et al (27) reported impaired cysteine metabolism
`in premature infants on total parenteral nutrition. All those stud(cid:173)
`ies indicate that limited cystathionase activity makes cyst( e )ine a
`conditionally essential amino acid in preterm infants. Zlotkin et
`al (28), nevertheless, reported that cysteine supplementation did
`not affect growth rate and nitrogen balance in parenterally fed
`term and preterm infants. It did slightly increase urinary
`3-methylhistidine excretion, however, suggesting that either
`muscle protein catabolism or muscle mass had increased. Also
`Malloy et al (29) did not find an improved nitrogen balance with
`cysteine supplementation, although plasma-free cyst(e)ine con(cid:173)
`centration increased. Contradictorily, findings from a recent
`study suggest that the transsulfuration pathway produces suffi(cid:173)
`cient amounts of cysteine in the parenterally fed preterm infant
`(30).
`Our study was performed when neonates received full enteral
`feeding supplied with a generous amount of methionine and
`shows that the cyst(e)ine synthesis pathway is active and suffi(cid:173)
`cient at this time. We studied the indicator oxidation during 5 h
`when infants were continuously fed. The standard feeding regi(cid:173)
`men of these infants in our neonatal intensive care unit dictates
`feeding every hour or every 2 h, depending on clinical consid(cid:173)
`erations. Thus, we studied neonates under physiologic circum(cid:173)
`stances. In our view, therefore, the absence of a postabsorptive
`state in these preterm infants does not necessitate the study of
`oxidation during 24 h.
`In conclusion, our findings reject our hypothesis that cys(cid:173)
`t( e )ine is a conditionally essential amino acid in 1-mo-old fully
`enterally fed LBW preterm infants with a mean GA of 33 wk.
`These findings show indirectly that activity of the enzyme cys(cid:173)
`tathionase is sufficient to synthesize adequate amounts of
`cyst(e)ine in these infants supplied with a generous amount of
`dietary methionine.
`
`We thank Ineke van Vliet for her support in performing the studies, Ko
`Hagoort for critical review of the manuscript, and Paul Mulder for statistical
`help. We also thank all the parents who consented for their infants to partic(cid:173)
`ipate in this study.
`The author's responsibilities were as follows-MAR: collected and ana(cid:173)
`lyzed the data and wrote the manuscript; RHTvB, HMAdB, and ACMD:
`recruited all patients; GV: analyzed the data; JBvG: designed the study and
`provided helpful comments on the manuscript. None of the authors had any
`financial or personal interest in any company or organization sponsoring the
`research.
`
`REFERENCES
`1. Zlotkin SH, Anderson GH. The development of cystathionase activity
`during the first year of life. Pediatr Res 1982; 16:65-8.
`2. Sturman JA, Gaull G, Raiha NC. Absence of cystathionase in human
`fetal liver: is cystine essential? Science 1970;169:74-6.
`3. Gaull G, Sturman JA, Raiha NC. Development of mammalian sulfur
`metabolism: absence of cystathionase in human fetal tissues. Pediatr Res
`1972;6:538-47.
`4. Snyderman SE, Boyer A, Norton PM, Roitman E, Holt LE Jr. The
`essential amino acid requirements of infants. IX. Isoleucine. Am J Clin
`Nutt 1964;15:313-21.
`
`Eton Ex. 1049
`5 of 6
`
`

`

`CYST(E)INE REQUIREMENTS IN LBW INFANTS
`
`1125
`
`5. Snyderman SE, Boyer A, Norton PM, Roitman E, Holt LE Jr. The
`essential amino acid requirements of infants. X. Methionine. Am J Clin
`Nutr 1964;15:322-30.
`6. Fuller MF, Garlick PJ Human amino acid requirements: can the contro(cid:173)
`versy be resolved? Annu Rev Nutr 1994;14:217-41.
`7. Rand WM, Young YR, Scrimshaw NS. Change of urinary nitrogen
`excretion in response to low-protein diets in adults. Am J Clin Nutr
`1976;29:639-44.
`8. Garlick P, Pencharz PB, Reeds P. Protein and amino acid. In: Panel on
`macronutrients: dietary reference intakes for energy, carbohydrates, fi(cid:173)
`ber, fat, fatty acids, cholesterol, protein and amino acids. Washington,
`DC: Institute of Medicine, National Academy of Sciences, 2005:589-
`768.
`9. Sparks JW. Human intrauterine growth and nutrient accretion. Semin
`Perinatol 1984;8:74-93.
`10. Widdowson EM, Spray CM. Chemical development in utero. Arch Dis
`Child 1951 ;26:205-14.
`11. Ziegler EE, O' Donnell AM, Nelson SE, Fomon SJ. Body composition of
`the reference fetus. Growth 1976;40:329-41.
`12. Shoveller AK, Brunton JA, Pencharz PB, Ball RO. The methionine
`requirement is lower in neonatal piglets fed parenterally than in those fed
`enterally. J Nutr 2003;133:1390-7.
`13. Ball RO, Bayley HS. Tryptophan requirement of the 2.5-kg piglet de(cid:173)
`termined by the oxidation of an indicator amino acid. J Nutr 1984;114:
`1741-6.
`14. Riedijk MA, Voortman G, van Goudoever JB. Use of [13C]bicarbonate
`for metabolic studies in preterm infants: intragastric versus intravenous
`administration. Pediatr Res 2005;58:861-4.
`15. van der Schoor SR, de Koning BA, Wattimena DL, Tibboel D, van
`Goudoever JB. Validation of the direct nasopharyngeal sampling
`method for collection of expired air in preterm neonates. Pediatr Res
`2004;55:50-4.
`16. van der Schoor SR, Reeds PJ, Stellaard F, et al. Lysine kinetics in preterm
`infants: the importance of enteral feeding. Gut 2004;53:38-43.
`17. Brunton JA, Ball RO, Pencharz PB. Determination of amino acid re(cid:173)
`quirements by indicator amino acid oxidation: applications in health and
`disease. Curr Opin Clin Nutr Metab Care 1998;1:449-53.
`
`18. Pencharz PB, Ball RO. Different approaches to define individual amino
`acid requirements. Annu Rev Nutr 2003;23: 101-16.
`19. Klein CJ. Nutrient requirements for preterm infant formulas. J Nutr
`2002; l 32(suppl): 1395S-577S.
`20. Zello GA, Menendez CE, Rafii M, et al. Minimum protein intake for the
`preterm neonate determined by protein and amino acid kinetics. Pediatr
`Res 2003;53:338-44.
`21. Widdowson E. Body composition of the fetus and infant. In: Visser H,
`ed. Fifth Nutricia Symposium: nutrition and metabolism of the fetus and
`infant. The Hague, the Netherlands: Martinus Nijhoff, 1979:169-77.
`22. Stegink LD, Den Besten L. Synthesis of cysteine from methionine in
`normal adult subjects: effect of route of alirnentation. Science 1972; 178:
`514-6.
`23. Shoveller AK, Brunton JA, House JD, Pencharz PB, Ball RO. Dietary
`cysteine reduces the methionine requirement by an equal proportion in
`both parenterally and enterally fed piglets. J Nutr 2003;133:4215-24.
`24. Van Goudoever JB, Sulkers EJ, Tinunerman M, et al. Amino acid so(cid:173)
`lutions for premature neonates during the first week of life: the role of

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket